232 related articles for article (PubMed ID: 11801691)
1. CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability.
Lobo FM; Scholl PR; Fuleihan RL
J Immunol; 2002 Feb; 168(3):1473-8. PubMed ID: 11801691
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.
Seyama K; Nonoyama S; Gangsaas I; Hollenbaugh D; Pabst HF; Aruffo A; Ochs HD
Blood; 1998 Oct; 92(7):2421-34. PubMed ID: 9746782
[TBL] [Abstract][Full Text] [Related]
3. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
Bhushan A; Covey LR
Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
[TBL] [Abstract][Full Text] [Related]
4. CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization.
de Saint Basile G; Tabone MD; Durandy A; Phan F; Fischer A; Le Deist F
Eur J Immunol; 1999 Jan; 29(1):367-73. PubMed ID: 9933119
[TBL] [Abstract][Full Text] [Related]
5. Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers.
O'Gorman MR; Zaas D; Paniagua M; Corrochano V; Scholl PR; Pachman LM
Clin Immunol Immunopathol; 1997 Nov; 85(2):172-81. PubMed ID: 9344700
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand.
Seyama K; Osborne WR; Ochs HD
J Biol Chem; 1999 Apr; 274(16):11310-20. PubMed ID: 10196221
[TBL] [Abstract][Full Text] [Related]
7. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells.
Facchetti F; Appiani C; Salvi L; Levy J; Notarangelo LD
J Immunol; 1995 Jun; 154(12):6624-33. PubMed ID: 7539026
[TBL] [Abstract][Full Text] [Related]
8. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
9. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".
Kroczek RA; Graf D; Brugnoni D; Giliani S; Korthüer U; Ugazio A; Senger G; Mages HW; Villa A; Notarangelo LD
Immunol Rev; 1994 Apr; 138():39-59. PubMed ID: 7915248
[TBL] [Abstract][Full Text] [Related]
10. CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
[TBL] [Abstract][Full Text] [Related]
11. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
Bhushan A; Barnhart B; Shone S; Song C; Covey LR
J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
[TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
Groeneweg M; Lankester AC; Bredius RG
Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
[TBL] [Abstract][Full Text] [Related]
13. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
[TBL] [Abstract][Full Text] [Related]
15. The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndrome.
Bartlett A; McCall J; Ameratunga R; Munn S
Clin Transplant; 2000 Dec; 14(6):520-8. PubMed ID: 11127303
[TBL] [Abstract][Full Text] [Related]
16. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development.
Kumanogoh A; Wang X; Lee I; Watanabe C; Kamanaka M; Shi W; Yoshida K; Sato T; Habu S; Itoh M; Sakaguchi N; Sakaguchi S; Kikutani H
J Immunol; 2001 Jan; 166(1):353-60. PubMed ID: 11123312
[TBL] [Abstract][Full Text] [Related]
17. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1).
Ramesh N; Fuleihan R; Geha R
Immunol Rev; 1994 Apr; 138():87-104. PubMed ID: 7520884
[No Abstract] [Full Text] [Related]
19. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives.
Prasad ML; Velickovic M; Weston SA; Benson EM
J Clin Pathol; 2005 Jan; 58(1):90-2. PubMed ID: 15623492
[TBL] [Abstract][Full Text] [Related]
20. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
